Other
Options granted (in shares)
West Pharmaceutical Services Options granted (in shares) increased by 237.7% to 65K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.6%, from 53.1K to 65K.
Analysis
StatementIncome Statement
SectionOther
CategoryOther
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026Apr 23, 2026
How to read this metric
An increase suggests an expansion of incentive programs or increased hiring, while a decrease may signal a shift in compensation strategy.
Detailed definition
This represents the total number of new stock options granted to employees and directors during the reporting period. It...
Peer comparison
Standard metric for evaluating dilution and compensation intensity across peers.
Metric ID:
other_share_based_compensation_arrangement_by_share_base_91ff6bHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 2.1K | 2.5K | 109.5K | 4.3K | 3K | 105.2K | 396 | 84.1K | 1.1K | 3.3K | 53.1K | 4.7K | 19.3K | 65K |
| QoQ Change | — | +21.4% | >999% | -96.0% | -30.9% | >999% | -99.6% | >999% | -98.7% | +196.1% | >999% | -91.1% | +308.4% | +237.7% |
| YoY Change | — | — | — | +109.1% | +18.9% | -3.9% | -90.9% | -20.1% | +183.6% | — | -36.9% | +319.9% | +479.2% | +22.6% |
Range396 – 109.5K
CAGR+188.8%
Avg YoY Growth+98.1%
Median YoY Growth+20.7%
Current Streak2 quarters growth
Options granted (in shares) at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's options granted (in shares)?
- West Pharmaceutical Services (WST) reported options granted (in shares) of 65K in Q1 2026.
- How has West Pharmaceutical Services's options granted (in shares) changed year-over-year?
- West Pharmaceutical Services's options granted (in shares) increased by 22.6% year-over-year, from 53.1K to 65K.
- What does options granted (in shares) mean?
- The total volume of new stock options issued to employees.